233 related articles for article (PubMed ID: 34919147)
1. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.
Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S
Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma research on zebrafish xenograft models: a systematic review.
Pliakopanou A; Antonopoulos I; Darzenta N; Serifi I; Simos YV; Katsenos AP; Bellos S; Alexiou GA; Kyritsis AP; Leonardos I; Vezyraki P; Peschos D; Tsamis KI
Clin Transl Oncol; 2024 Feb; 26(2):311-325. PubMed ID: 37400666
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish.
Ai X; Ye Z; Xiao C; Zhong J; Lancman JJ; Chen X; Pan X; Yang Y; Zhou L; Wang X; Shi H; Zhang D; Yao Y; Cao D; Zhao C
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35199829
[TBL] [Abstract][Full Text] [Related]
4. An orthotopic glioblastoma animal model suitable for high-throughput screenings.
Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281
[TBL] [Abstract][Full Text] [Related]
5. Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion.
Gamble JT; Reed-Harris Y; Barton CL; La Du J; Tanguay R; Greenwood JA
Biochem Biophys Res Commun; 2018 Dec; 506(4):833-839. PubMed ID: 30389143
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
Xu Z; Kader M; Sen R; Placantonakis DG
Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
8. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.
Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C
Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081
[TBL] [Abstract][Full Text] [Related]
9. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.
Alberti G; Amico MD; Caruso Bavisotto C; Rappa F; Marino Gammazza A; Bucchieri F; Cappello F; Scalia F; Szychlinska MA
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791432
[TBL] [Abstract][Full Text] [Related]
10. Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts.
Koessinger AL; Koessinger D; Stevenson K; Cloix C; Mitchell L; Nixon C; Gomez-Roman N; Chalmers AJ; Norman JC; Tait SWG
Sci Rep; 2020 Sep; 10(1):15361. PubMed ID: 32958777
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
[TBL] [Abstract][Full Text] [Related]
12. Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain.
Peglion F; Coumailleau F; Etienne-Manneville S
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969108
[TBL] [Abstract][Full Text] [Related]
13. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
15. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
[TBL] [Abstract][Full Text] [Related]
16. Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.
Kerstetter-Fogle AE; Harris PLR; Brady-Kalnay SM; Sloan AE
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698368
[TBL] [Abstract][Full Text] [Related]
17. Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico.
Williams AS; Wilk EJ; Fisher JL; Lasseigne BN
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1874. PubMed ID: 37533331
[TBL] [Abstract][Full Text] [Related]
18. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
[TBL] [Abstract][Full Text] [Related]
19. Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.
Welker AM; Jaros BD; Puduvalli VK; Imitola J; Kaur B; Beattie CE
Dis Model Mech; 2016 Feb; 9(2):199-210. PubMed ID: 26659251
[TBL] [Abstract][Full Text] [Related]
20. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
Kiang KM; Chan AA; Leung GK
BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
